SynthesisBMC endocrine disorders2022

Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of double-blind, randomized, placebo-controlled clinical trials.

Jing Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.